Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASTRO 2022 | Translating cancer genetics and epigenetics research into clinical practice

Omar Mian • 25 Oct 2022
ASTRO 2022
General

Omar Mian, MD, PhD, Cleveland Clinic, Cleveland, OH, gives an overview of the ongoing prospective clinical trials furthering research into cancer genetics and epigenetics with the aim to improve patient-tailored treatment. This interview took place at the American Society for Radiation Oncology (ASTRO) 2022 Congress in San Antonio, Tx.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Omar Mian

3:12
Impact of HSD3B1 gene alterations on treatment response in patients with prostate cancer
Omar Mian • 25 Oct 2022
2:31
18F-clofarabine as a predictive biomarker for response to DCK-dependent chemotherapeutics
Omar Mian • 25 Oct 2022
1:14
Role of cancer epigenetics in tumour classification
Omar Mian • 25 Oct 2022
1:55
Latest advances in tumour genetics research for prostate cancer
Omar Mian • 25 Oct 2022

Related Videos

0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
3:10
PALOMA: subcutaneous amivantamab in advanced solid tumors
Natasha Leighl • 17 Apr 2024
The content of VJOncology is intended for healthcare professionals